The first stop for professional medicines advice

Trusts, Medicines planning

14 results

RelevanceNewest firstOldest firstTitle
Applied filters

Patient Group Direction use in virtual ward services

28 March 2023Considerations required before implementing Patient Group Direction (PGDs) in virtual ward services

Supplying contrast agents under a Patient Group Direction

12 August 2020Advice on the preparation and/or administration of contrast agents supplied under a Patient Group Direction (PGD).

National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice

4 August 2020The National Pharmaceutical Supply Group (NPSG) currently advises against participation in advisory boards sponsored by Manufacturers (Marketing Authorisation Holders). This NHMC paper supports this advice…

National Homecare Medicines Committee (NHMC) Homecare Digital Strategy

4 August 2020This is the NHMC and NCHA joint digital strategy and roadmap for the next 5 years. It sets out a direction of travel for homecare…

Medicines Shortages and Patient Group Directions

16 December 2019This article outlines how PGDs can be managed to allow for their continued use in cases of medicines shortages.

National Homecare Medicines Committee (NHMC) Homecare Risk Assessment

10 December 2019To support organisations in establishing a robust risk assessment process for new homecare medicines services the NHMC has developed a tool for local use.  …

Using medicines under PGD as part of a clinical trial or study

26 June 2019Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot

National Homecare Medicines Committee (NHMC) Standard Service Areas

12 April 2019In March 2018 NHMC approved a list of standard service areas which will be incorporated into version 6 of the national KPI dataset. Homecare providers…

National Homecare Medicines Committee (NHMC) Homecare Service Proposal (HSP) Form

9 April 2019The Homecare Service Proposal (HSP) Form is to be completed by pharmaceutical manufacturers where there are new homecare medicines services or where there are changes…

Pharmacy Institutional Readiness for Marketed CAR-T Therapy: Guidance for Chief Pharmacists V4 (updated January 2020)

2 October 2018This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T Therapy.